{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:27:20Z","timestamp":1771302440687,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HAN university of Applied Sciences"},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to identify healthcare needs, expectations, utilization, and the experienced treatment effects in a population of Dutch patients with hereditary spastic paraplegia (HSP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We distributed an online questionnaire among 194 adult persons with HSP in the Netherlands, of which 166 returned a fully completed version. After applying predefined exclusion criteria, 109 questionnaires from persons with pure HSP were analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Healthcare needs and expectations were primarily focused on the relief of muscle stiffness and reduction of balance and gait impairments (65\u201380%), but many participants also expressed needs regarding relief of non-motor symptoms (e.g. pain, fatigue), emotional problems, impaired sleep and self-care capacity, and participation problems (&gt;\u200960%). Remarkably, despite these frequent needs, relatively few participants (&lt;\u200933%) expected to be able to improve in these additional domains. Rehabilitation physicians and physiotherapists were more frequently consulted than neurologists and occupational therapists, respectively. Physiotherapy was the most often proposed non-pharmacological intervention (85%), followed by orthopedic footwear (55%) and splints (28%). Approximately one third of the participants was never offered any pharmacological (spasmolytic) treatment. Spasmolytic oral drugs, injections, and intrathecal baclofen were given to 41%, 26%, and 5% of the participants, respectively. Independent of the type of pharmacological intervention, 35\u201346% of these participants experienced decreased spastiticy and improved general fitness. Other experienced effects differed per type of intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on this web-based survey in the Netherlands, there seems to be ample room for improvement to meet and attune the healthcare needs and expectations of people with HSP concerning both their motor and non-motor symptoms and functional limitations. In addition, the provision of adequate information about non-pharmacological and pharmacological interventions seems to be insufficient for many patients to allow shared decision making. These conclusions warrant a more pro-active attitude of healthcare providers as well as an interdisciplinary approach for a substantial proportion of the HSP population, also involving professionals with a primary occupational and\/or psychosocial orientation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01915-0","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:03:43Z","timestamp":1624525423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Healthcare needs, expectations, utilization, and experienced treatment effects in patients with hereditary spastic paraplegia: a web-based survey in the Netherlands"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-4590","authenticated-orcid":false,"given":"Hans C. J. W.","family":"Kerstens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas J. H.","family":"Van Lith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"Nijkrake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert J. M.","family":"De Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A. C.","family":"Van den Bemd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J. E. M.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fheodoroff","family":"Klemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart P. C.","family":"Van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Van der Wees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C. H.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"issue":"2","key":"1915_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","volume":"69","author":"C McDermott","year":"2000","unstructured":"McDermott C, White K, Bushby K, Shaw P. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry. 2000;69(2):150\u201360.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1915_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 2013;126(3):307\u201328.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1915_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11910-996-0011-1","volume":"6","author":"JK Fink","year":"2006","unstructured":"Fink JK. Hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 2006;6(1):65\u201376.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"1915_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127\u201338.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1915_CR5","first-page":"64020","volume":"15","author":"BJH van Lith","year":"2020","unstructured":"van Lith BJH, Kerstens HCJW, van den Bemd LAC, der Sanden MWGN, Weerdesteyn V, Smeets RJEM, et al. Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands. Orphanet J Rare Dis. 2020;15(1):64020-1338\u20134.","journal-title":"Orphanet J Rare Dis"},{"key":"1915_CR6","first-page":"1","volume":"13","author":"HCJW Kerstens","year":"2019","unstructured":"Kerstens HCJW, Satink T, Nijkrake MJ, Bert De Swart JM, Bas Van Lith JH, Geurts ACH, et al. Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia. Disabil Rehabil. 2019;13:1\u20138.","journal-title":"Disabil Rehabil"},{"key":"1915_CR7","first-page":"CD009689","volume":"6","author":"M Demetrios","year":"2013","unstructured":"Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev. 2013;6:CD009689.","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"1915_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/09638288.2016.1198432","volume":"39","author":"M Barnes","year":"2017","unstructured":"Barnes M, Kocer S, Murie Fernandez M, Balcaitiene J, Fheodoroff K. An international survey of patients living with spasticity. Disabil Rehabil. 2017;39(14):1428\u201334.","journal-title":"Disabil Rehabil"},{"issue":"6","key":"1915_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1474-4422(14)70055-9","volume":"13","author":"IHWM Sturkenboom","year":"2014","unstructured":"Sturkenboom IHWM, Graff MJL, Hendriks JCM, Veenhuizen Y, Munneke M, Bloem BR, et al. Efficacy of occupational therapy for patients with Parkinson\u2019s disease: a randomised controlled trial. Lancet Neurol. 2014;13(6):557\u201366.","journal-title":"Lancet Neurol"},{"key":"1915_CR10","doi-asserted-by":"crossref","unstructured":"Steultjens EMJ, Dekker J, Bouter LM, Leemrijse CJ, van den Ende C,H.M. Evidence of the efficacy of occupational therapy in different conditions: an overview of systematic reviews. Clin Rehabil. 2005; 2021;19(3):247\u201354.","DOI":"10.1191\/0269215505cr870oa"},{"issue":"11","key":"1915_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3109\/09638288.2013.824032","volume":"36","author":"J Grose","year":"2014","unstructured":"Grose J, Freeman J, Marsden J. Service delivery for people with hereditary spastic paraparesis living in the South West of England. Disabil Rehabil. 2014;36(11):907\u201313.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"1915_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gaitpost.2012.12.006","volume":"38","author":"M de Niet","year":"2013","unstructured":"de Niet M, Weerdesteyn V, de Bot ST, van de Warrenburg BPC, Geurts AC. Does calf muscle spasticity contribute to postural imbalance? A study in persons with pure hereditary spastic paraparesis. Gait Posture. 2013;38(2):304\u20139.","journal-title":"Gait Posture"},{"key":"1915_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fneur.2019.00003","volume":"10","author":"M Bellofatto","year":"2019","unstructured":"Bellofatto M, De Michele G, Iovino A, Filla A, Santorelli FM. Management of hereditary spastic paraplegia: a systematic review of the literature. Front Neurol. 2019;10:3.","journal-title":"Front Neurol"},{"issue":"05","key":"1915_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09638288.2020.1769207","volume":"06","author":"G Williams","year":"2020","unstructured":"Williams G, Singer BJ, Ashford S, Hoare B, Hastings-Ison T, Fheodoroff K, et al. A synthesis and appraisal of clinical practice guidelines, consensus statements and Cochrane systematic reviews for the management of focal spasticity in adults and children. Disabil Rehabil. 2020;06(05):1\u201311.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"1915_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/1468-0009.12091","volume":"92","author":"PJ Van Der Wees","year":"2014","unstructured":"Van Der Wees PJ, Nijhuis-van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. Milbank. 2014;92(4):754\u201375.","journal-title":"Milbank"},{"key":"1915_CR16","unstructured":"Dekker N. Hereditaire spastische paraparese (HSP) en primaire laterale sclerose (PLS). Healthcare professional information. Soest: Spierziekten Nederland; 2017 March 2017. Report No.: 1."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01915-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01915-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01915-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:12:13Z","timestamp":1624525933000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01915-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01915-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the regional medical ethics committee \u201cCommissie Mensgebonden Onderzoek Arnhem-Nijmegen\u201d (Number 2016-2922) and conducted according to the declaration of Helsinki. All participants were adults who consented to participate with written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}